Cytokinetics number of employees
WebSep 30, 2024 · Number of Employees. 130. Revenue / Employee. $429,231. Peak Revenue. $55.8M (2024) Number of Employees. 130. Revenue / Employee. $429,231. Cytokinetics Jobs. Location. Job Title. Distance. ... and more, in order to inform job seekers about Cytokinetics. The employee data is based on information from people who have …
Cytokinetics number of employees
Did you know?
WebCompany Culture at Cytokinetics Inc. The employee experience below at Cytokinetics Inc, compared to a typical company. 92% of employees at Cytokinetics Inc say it is a … WebFeb 17, 2024 · $94.6 M FY, 2024 Company summary Overview Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.
WebNov 18, 2024 · Founded in 1997, Cytokinetics is an established company that loves to hire graduates from San Francisco State University, with 24.1% of its employees having … WebEvery employee contributes something unique to our shared goal of improving the lives of people with diseases characterized by muscle dysfunction, weakness or loss, and it is only with our employees’ …
WebSee the company profile for Cytokinetics, Incorporated (CYTK) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ... WebApr 4, 2024 · SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new employees, whose employment commenced in March 2024, as a material inducement …
WebWe have pioneered the discovery and optimization of sarcomere-directed potential medicines, and we have conducted more than 50 clinical trials.
WebFeb 28, 2024 · Cytokinetics to Host Conference Call and Webcast on March 1, 2024 at 8:30 am Eastern Time ... Upon registration, participants will receive a dial-in number and a unique passcode to access the call. earth rider cyclingWebApr 10, 2024 · 13 Analysts CYTK Stock Overview Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. About the company Rewards Revenue is forecast to grow 46.65% per year Risk Analysis ct of neck with contrast cptWebMar 27, 2024 · CYTK. KK3A. SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated ( Nasdaq: CYTK) today announced the release of its inaugural Corporate Responsibility Report, outlining the Company’s commitment to social and environmental responsibility, ethics and governance and patient and … ct of neck without contrast cptWebCytokinetics is a biopharmaceutical company developing therapies for debilitating diseases. Search Crunchbase. ... Contact Email [email protected]; Phone Number 6506243010; ... earth rider mnWebApr 6, 2024 · Free-Float. 95,1%. More Financials. Company. Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically … ct of neck soft tissue with contrastWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle … earthridge international ltdWebAt Cytokinetics, we provide more than a job, we provide an opportunity to contribute to something bigger than any one of us. Every employee contributes something unique to our shared goal of improving the lives of … earthright holdings inc